지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2009.10
- 수록면
- 238 - 245 (8page)
이용수
초록· 키워드
오류제보하기
Purpose: Axillary lymph node metastasis is one of the most important prognostic factors in breast cancer. Previous reports show differences that clinicopathologic factors influence the systemic recurrence and survival in axillary lymph node negative breast cancer. Thus, we have attempted to determine the prognostic factors influence on the systemic recurrence and survival in axillary lymph node negative breast cancer.
Methods: We retrospectively reviewed the data of 1,351 node negative breast cancer patients who underwent curative surgery to determine the prognostic factors such as age, sex, body mass index (BMI), family history, bilateral breast cancer, operation method, tumor size, stage, histologic grade, number of resected lymph nodes, hormone receptor status, overexpression of p53 and c-erbB2, and adjuvant therapy that influence the systemic recurrence and 10-year-distant relapse-free survival.
Results: Systemic recurrence occurred in 58 patients (4.3%) during 53.3 months median follow up period. The tumor size (P=0.001), stage (P=0.005), histologic grade (P=0.049). ER (P=0.028), PR (P=0.002), overexpression of p53 (P=0.001) and bilateral breast cancer (P=0.043) were statistically significant factors that influenced the systemic recurrence. In multivariate analysis, only tumor size was associated with the systemic recurrence (P=0.003). Tumor size (P=0.004), histologic grade (P=0.035), ER (P=0.046), PR (P=0.001) and bilateral cancer (P=0.003) were statistically significant factors that influenced 10-year-distant relapse-free survival.
Conclusion: The larger tumor size was determined to be an independent prognostic value in axillary lymph node negative breast cancer.
Methods: We retrospectively reviewed the data of 1,351 node negative breast cancer patients who underwent curative surgery to determine the prognostic factors such as age, sex, body mass index (BMI), family history, bilateral breast cancer, operation method, tumor size, stage, histologic grade, number of resected lymph nodes, hormone receptor status, overexpression of p53 and c-erbB2, and adjuvant therapy that influence the systemic recurrence and 10-year-distant relapse-free survival.
Results: Systemic recurrence occurred in 58 patients (4.3%) during 53.3 months median follow up period. The tumor size (P=0.001), stage (P=0.005), histologic grade (P=0.049). ER (P=0.028), PR (P=0.002), overexpression of p53 (P=0.001) and bilateral breast cancer (P=0.043) were statistically significant factors that influenced the systemic recurrence. In multivariate analysis, only tumor size was associated with the systemic recurrence (P=0.003). Tumor size (P=0.004), histologic grade (P=0.035), ER (P=0.046), PR (P=0.001) and bilateral cancer (P=0.003) were statistically significant factors that influenced 10-year-distant relapse-free survival.
Conclusion: The larger tumor size was determined to be an independent prognostic value in axillary lymph node negative breast cancer.
목차
서론
방법
결과
고찰
결론
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
10개 이상의 액와임파절 전이를 가진 유방암 환자에 대한 임상적 고찰
Annals of Surgical Treatment and Research
2000 .10
-
유방암의 액와림프절 전이에 대한 관련인자
Annals of Surgical Treatment and Research
1992 .12
-
유방암에서 액와림프절 전이의 예측 인자
Annals of Surgical Treatment and Research
1999 .12
-
T1 유방암 환자에서 액와림프절 전이의 예측인자
Annals of Surgical Treatment and Research
2000 .11
-
T1 유방암 환자의 액와 림프절 전이율
Annals of Surgical Treatment and Research
2001 .04
-
림프절 전이가 없는 유방암의 임상적 고찰
Annals of Surgical Treatment and Research
2000 .05
-
10개 이상 액와 림프절 전이를 보인 유방암 환자의 예후
Annals of Surgical Treatment and Research
2008 .10
-
T1 유방암 환자에서 액와부 림프절 전이
Annals of Surgical Treatment and Research
2000 .09
-
유방암의 액와림프절 전이수와 다른 예후인자의 관계
Annals of Surgical Treatment and Research
1996 .06
-
조기유방암에서 유방보존술 후 재발에 영향을 주는 인자
Radiation oncology journal : ROJ
1997 .01
-
유방암 수술 환자에서 액와임파절 전이 Level(Level of Axillary Lymph Node)의 의의
Annals of Surgical Treatment and Research
1992 .06
-
유방암의 수술후 생존율과 예후인자 분석
Annals of Surgical Treatment and Research
1998 .05
-
액와림프절 전이 음성 유방암에서 미세전이의 의의
Annals of Surgical Treatment and Research
1999 .09
-
유방암 수술에 있어서 내시경을 이용한 액와림프절 절제술
Annals of Surgical Treatment and Research
1998 .06
-
Lymph node ratio as a prognostic factor for pathologic N3a breast cancer patients with 10 or more metastatic axillary lymph nodes
대한외과학회 학술대회 초록집
2017 .11
-
액와 임파절 전이가 10개 이상인 유방암 환자의 예후
Annals of Surgical Treatment and Research
1997 .08
-
감시림프절 절제술만을 시행한 유방암 환자의 단기 추적 관찰 성적
Annals of Surgical Treatment and Research
2007 .10
-
액와 림프절 전이를 증세로 나타내는 잠재성 유방암
Annals of Surgical Treatment and Research
1998 .04
-
Predictive Role of Tumor Size in Breast Cancer with Axillary Lymph Node Involvement - Can Size of Primary Tumor be used to Omit an Unnecessary Axillary Lymph Node Dissection?
Asian Pacific journal of cancer prevention : APJCP
2013 .01
-
유방암 환자의 조기재발에 관한 예측인자
Annals of Surgical Treatment and Research
1989 .09
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2013-514-002650502